ConvaTec ( (GB:CTEC) ) just unveiled an announcement.
Convatec Group Plc announced the vesting of share awards under its Long Term Incentive Plan for Jonny Mason, the Chief Financial Officer. On March 14, 2025, Mason’s performance share awards vested, and on March 18, 2025, a portion of these shares were sold to cover tax and national insurance obligations. This transaction reflects the company’s ongoing commitment to aligning management incentives with shareholder interests, potentially impacting the company’s financial strategy and market perception.
More about ConvaTec
Convatec is a global medical products and technologies company focused on solutions for managing chronic conditions. The company holds leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, offering products and services in around 90 countries. Convatec’s solutions aim to improve patient outcomes and reduce care costs, with revenues exceeding $2 billion in 2024. The company is part of the FTSE 100 Index.
YTD Price Performance: 16.64%
Average Trading Volume: 5,438,993
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £5.21B
Find detailed analytics on CTEC stock on TipRanks’ Stock Analysis page.